Multidrug-Resistant Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in a Dairy Herd: Distribution and Antimicrobial Resistance Profiles
- PMID: 38534676
- PMCID: PMC10967312
- DOI: 10.3390/antibiotics13030241
Multidrug-Resistant Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in a Dairy Herd: Distribution and Antimicrobial Resistance Profiles
Abstract
This study investigated the presence, distribution, and antimicrobial resistance profiles of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in a dairy herd located in Northern Italy. The feces of clinically healthy calves, their mothers, and the cows treated for mastitis, as well as water, environmental samples, and waste milk were collected and subjected to bacteriological culture on CHROMagarTM ESBL plates. A questionnaire was administered to identify risk factors. The isolates were identified as E. coli by MALDI-TOF MS and subjected to the double-disk synergy test (DDST) and minimal inhibitory concentration (MIC) assay. As a result, ESBL E. coli was isolated from the feces of 28 of 37 (75.67%) calves, the feces of 2 of 3 (66.67%) treated cows, 8 of 14 (57.15%) environmental samples, and waste milk. All ESBL isolates showed multiple resistances and were categorized as multidrug-resistant (MDR). Several risk factors for ESBL E. coli selection and diffusion were identified, including lack of routine cleaning of calf feeding and housing equipment, administration of waste milk to male calves, and blanket dry cow therapy. In conclusion, this study highlighted the presence of MDR, ESBL E. coli in the feces of most dairy calves, and their association with different sample sources. Accordingly, adding to the prudent use of antibiotics, the adoption of adequate farm hygiene and biosecurity measures might also help prevent the spread and transmission of ESBL E. coli within the herd.
Keywords: ESBL E. coli; antimicrobial resistance; biosecurity; dairy calves; multidrug-resistant; waste milk.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


References
-
- Antimicrobial Resistance Surveillance in Europe 2022—2020 Data. [(accessed on 29 January 2024)]. Available online: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance....
-
- Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2022. [(accessed on 29 January 2024)]. Available online: https://www.who.int/publications-detail-redirect/9789240062702.
-
- European Centre for Disease Prevention and Control. European Food Safety Authority. European Medicines Agency Third Joint Inter-Agency Report on Integrated Analysis of Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Humans and Food-Producing Animals in the EU/EEA. EFSA J. 2021;19:e06712. doi: 10.2903/j.efsa.2021.6712. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials